Vertex Pharmaceuticals Incorporated
VRTX
$387.18
-$1.76-0.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.13% | -39.03% | -45.48% | -45.30% | -48.42% |
| Total Receivables | 14.33% | 0.66% | 2.94% | 13.77% | 6.42% |
| Inventory | 63.93% | 67.22% | 63.16% | 56.79% | 51.55% |
| Prepaid Expenses | 21.08% | 22.86% | -14.58% | -11.55% | 12.98% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -73.56% | 62.33% | 139.84% | -76.24% | 415.38% |
| Total Current Assets | 16.62% | -24.68% | -32.15% | -33.29% | -35.55% |
|
|
|||||
| Total Current Assets | 16.62% | -24.68% | -32.15% | -33.29% | -35.55% |
| Net Property, Plant & Equipment | 49.60% | 77.32% | 77.89% | 75.25% | 22.40% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -48.00% | -47.16% | -1.67% | 37.77% | 38.75% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23.48% | 26.14% | 20.62% | 53.16% | 60.24% |
| Total Assets | 19.39% | -4.34% | -0.87% | 2.37% | -1.07% |
|
|
|||||
| Total Accounts Payable | 34.89% | 26.64% | 13.18% | 5.29% | -9.67% |
| Total Accrued Expenses | 11.25% | 5.58% | 2.81% | 10.75% | 13.16% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 10.27% | -- | -- |
| Total Finance Division Other Current Liabilities | 52.31% | -40.43% | -20.48% | -9.42% | -28.57% |
| Total Other Current Liabilities | 52.31% | -40.43% | -20.48% | -9.42% | -28.57% |
| Total Current Liabilities | 16.67% | -0.33% | 0.48% | 10.38% | 5.82% |
|
|
|||||
| Total Current Liabilities | 16.67% | -0.33% | 0.48% | 10.38% | 5.82% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 63.64% | 128.63% | 128.67% | 128.67% | 21.60% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 36.35% | 11.52% | 2.75% | 7.36% | 15.47% |
| Total Liabilities | 28.07% | 18.87% | 18.91% | 26.78% | 9.81% |
|
|
|||||
| Common Stock & APIC | -15.67% | -15.26% | -10.43% | -5.91% | -3.63% |
| Retained Earnings | 47.56% | -8.80% | -5.28% | -5.23% | -6.02% |
| Treasury Stock & Other | -549.33% | 293.64% | 993.71% | 1,060.00% | 156.53% |
| Total Common Equity | 16.25% | -11.05% | -6.66% | -5.34% | -4.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 16.25% | -11.05% | -6.66% | -5.34% | -4.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 16.25% | -11.05% | -6.66% | -5.34% | -4.50% |
|
|
|||||